Clinical Trial Update: Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of LAS 34273 in moderate to severe stable chronic obstructive pulmonary disease (COPD); results were posted af…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• LAS 34273

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2012-11-01